Clinical Trials List
2024-11-01 - 2029-08-31
Phase III
Recruiting10
ICD-10C18.3
Malignant neoplasm of hepatic flexure
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9153.0
Malignant neoplasm of hepatic flexure colon
-
-
Trial Applicant
AbbVie
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/13
Investigators and Locations
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 余紹銘 無
- Yung-Chia Kao 無
- Tsai-Sheng Yang 無
- 張境夫 無
- 黃振洋 無
- 呂嘉偉 無
- Jen-Shi Chen 無
- 賴盈傑 無
- Wen-Chi Chou 無
- 黃文冠 無
- Chia-Hsun Hsieh 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 洪逸平 無
- Chien-An Liu 無
- Chueh-Chuan Yen 無
- 吳紋綺 無
- 唐振育 無
- 姜乃榕 無
- 陳明晃 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
460 participants
